Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Change in Account Payables (2016 - 2019)

Sunshine Biopharma (SBFM) has disclosed Change in Account Payables for 8 consecutive years, with $33797.0 as the latest value for Q4 2019.

  • For the quarter ending Q4 2019, Change in Account Payables fell 19.32% year-over-year to $33797.0, compared with a TTM value of -$18692.0 through Dec 2019, down 151.21%, and an annual FY2020 reading of -$35012.0, down 87.31% over the prior year.
  • Change in Account Payables was $33797.0 for Q4 2019 at Sunshine Biopharma, up from -$21040.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $342944.0 in Q2 2017 and bottomed at -$359099.0 in Q3 2017.
  • Average Change in Account Payables over 5 years is $533.6, with a median of -$146.5 recorded in 2017.
  • The sharpest move saw Change in Account Payables crashed 6587.13% in 2018, then soared 18113.93% in 2019.
  • Year by year, Change in Account Payables stood at $11953.0 in 2015, then surged by 643.24% to $88839.0 in 2016, then tumbled by 81.62% to $16326.0 in 2017, then soared by 156.59% to $41891.0 in 2018, then dropped by 19.32% to $33797.0 in 2019.
  • Business Quant data shows Change in Account Payables for SBFM at $33797.0 in Q4 2019, -$21040.0 in Q3 2019, and $21977.0 in Q2 2019.